Table 2. Schedule of assessments.

Period (duration)	Open Label Treatment Period (10 Weeks)						Double-Blind Period (4 Weeks)
Week	0 (Baseline)	2	4	6	8	10	14
DEXA	X					X
Behavioral questionnaire	X					X
Fasting glucose	X	X	X	X	X	X	X
Ghrelin, leptin, triglycerides, Total C, LDL-C, HDL-C, non-HDL-C, comprehensive metabolic panel	X					X	X
Hyperphagia questionnaire	X	X	X	X	X	X	X
Resting energy expenditure, respiratory quotient	X		X		X	X	X
Pharmacokinetic blood sampling						X	X